Financial Statements · Financial Reporting
PharmaSynth AS
Official identifier 11044101Record date 31 Dec 2019
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2019
- Period start
- 1 Jan 2019
- Submitted date
- 5 Oct 2020
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 239,082 |
| Balance sheet | Cash and cash equivalents | 157,471 |
| Balance sheet | Current assets | 213,484 |
| Balance sheet | Current liabilities | 45,479 |
| Balance sheet | Equity | 182,364 |
| Balance sheet | Share capital at nominal value | 60,908 |
| Balance sheet | Non-current assets | 25,598 |
| Balance sheet | Non-current liabilities | 11,239 |
| Balance sheet | Retained earnings (loss) from previous periods | 72,485 |
| Kahjumi katmise ettepanek | Retained earnings (loss) from previous periods | 72,485 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -10,931 |
| Income statement scheme 1 | Labour costs | -180,026 |
| Income statement scheme 1 | Revenue | 319,371 |
| Income statement scheme 1 | Annual period profit / loss | 42,880 |
| Income statement scheme 1 | Operating profit (loss) | 42,713 |
| Income statement scheme 1 | Profit (loss) before income tax | 42,880 |
| Note: Labour costs | Employees | 8 |
| Note: Labour costs | Labour costs | 180,026 |
Linked company
Company: PharmaSynth AS